
PRESENTATION

PRESENTATION

Pr Xavier CARCOPINO
SFCPCV President, France

Dr Jean-Luc MERGUI
IFCPC President, France
A word from both presidents : the president of the local committee and IFCPC president
The International Federation of Cervical Pathology and Colposcopy (IFCPC) invites you to participate in the XIX IFCPC World Congress, to be held in Paris – Versailles, France, from June 4th to 6th, 2026.
This will be an opportunity to share the most recent scientific data on the prevention of cervical cancer
and HPV (human papillomavirus)-induced lesions in the lower genital tract. Key topics include:
● How to implement effective vaccination and evaluate the results.
● How to improve screening methods (the role of visual methods, cytology, HPV testing, genotyping, double immunostaining (CINtec), and methylation).
● What information should we provide to patients, and what are the psychological consequences of these virological tests?
● How to manage low-grade lesions, CIN2.
● How to improve the quality criteria of colposcopic examinations, and which classification to use.
● Management of immunocompromised patients and HPV during pregnancy.
● Post-therapeutic follow-up and the management of multifocal lesions (vaginal, vulvar, anal).
All of these topics will be discussed by the best experts from the five continents, allowing us to compare our experiences and improve our practices.
In the magnificent setting of the Versailles Palais des Congrès, we will exchange and share the latest scientific news over three days during a high-quality international program in a friendly and collegial environment.


Pr Xavier CARCOPINO
SFCPCV President, France
Dr Jean-Luc MERGUI
IFCPC President, France
A word from both presidents : the president of the local committee and IFCPC president
The International Federation of Cervical Pathology and Colposcopy (IFCPC) invites you to participate in the XIX IFCPC World Congress, to be held in Paris – Versailles, France, from June 4th to 6th, 2026.
This will be an opportunity to share the most recent scientific data on the prevention of cervical cancer
and HPV (human papillomavirus)-induced lesions in the lower genital tract. Key topics include:
● How to implement effective vaccination and evaluate the results.
● How to improve screening methods (the role of visual methods, cytology, HPV testing, genotyping, double immunostaining (CINtec), and methylation).
● What information should we provide to patients, and what are the psychological consequences of these virological tests?
● How to manage low-grade lesions, CIN2.
● How to improve the quality criteria of colposcopic examinations, and which classification to use.
● Management of immunocompromised patients and HPV during pregnancy.
● Post-therapeutic follow-up and the management of multifocal lesions (vaginal, vulvar, anal).
All of these topics will be discussed by the best experts from the five continents, allowing us to compare our experiences and improve our practices.
In the magnificent setting of the Versailles Palais des Congrès, we will exchange and share the latest scientific news over three days during a high-quality international program in a friendly and collegial environment.
KEY FIGURES
19th CONGRESS SINCE 1972
47 NATIONAL SOCIETES
LATEST EDITIONS

Mar Del Plaza, Argentina

Graz, Austria

Orlando, USA

London, UK

Tokyo, Japan

Sao Paolo, Brazil

Rome, Italy

Chicago, USA

Sidney, Australia

Buenos Aires, Argentina

Barcelona, Spain

Cancun, Mexico

Auckland, New Zealand

Rio de Janeiro, Brazil

London, UK

Orlando, USA

Hyberbad, India (virtual)

Cartagena, Colombia

Paris, France

Beijing, China
LATEST EDITIONS

Mar Del Plaza, Argentina

Graz, Austria

Orlando, USA

London, UK

Tokyo, Japan

Sao Paolo, Brazil

Rome, Italy

Chicago, USA

Sidney, Australia

Buenos Aires, Argentina

Barcelona, Spain

Cancun, Mexico

Auckland, New Zealand

Rio de Janeiro, Brazil

London, UK

Orlando, USA

Hyberbad, India (virtual)

Cartagena, Colombia

Paris, France

Beijing, China